“To Evaluate the Effectiveness of Dpp4 Inhibitors in Relation to Blood Sugar and Lipid Profile”, IJPHRD, vol. 13, no. 3, pp. 175–179, Jun. 2022, doi: 10.37506/ijphrd.v13i3.18192.